Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myosin heavy chain 2 (MYH2) is a protein encoded by the MYH2 gene in humans. It is a member of the class II myosin heavy chains and plays a critical role in skeletal muscle contraction. MYH2 encodes one of several isoforms of type II skeletal muscle myosins, generating mechanical force by interacting with actin filaments within sarcomeres. Mutations or dysfunctions involving MYH2 can lead to various muscular disorders, including Chronic Progressive External Ophthalmoplegia (CPEO).
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myosin Heavy Chain 2 (MYH2).